← Browse by Condition
Medical Condition

arrhythmias cardiac

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for arrhythmias cardiac sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — arrhythmias cardiac Clinical Trials

How many clinical trials are currently recruiting for arrhythmias cardiac?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for arrhythmias cardiac, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for arrhythmias cardiac?
arrhythmias cardiac research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a arrhythmias cardiac clinical trial?
Eligibility criteria for arrhythmias cardiac trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Biosense Webster, Inc. 1 trial
University Hospital of Ferrara 1 trial
The Cleveland Clinic 1 trial
Stanford University 1 trial

Recruiting Clinical Trials

NCT07727057
Recruiting
A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treatment of Ventricular Arrhythmias
Enrollment
90 pts
Location
Belgium
Sponsor
Biosense Webster, Inc.
View Trial →
NCT06311149
Recruiting
Multicenter Evaluation of Patients Using LATITUDE Monitoring System
Enrollment
20,000 pts
Location
Italy
Sponsor
University Hospital of Ferrara
View Trial →
NCT00921986
Recruiting
Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
Enrollment
2,000 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT05371405
Recruiting
Machine Learning in Atrial Fibrillation
Enrollment
120 pts
Location
United States
Sponsor
Stanford University
View Trial →

Related Conditions

cardiovascular diseases (1) heart failure (1) sudden cardiac death (1) atrial fibrillation (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology